In sarcopenia, the downregulation of SLC38A1 leads to inadequate amino acid supply to muscle cells, inhibiting protein synthesis and causing metabolic disorders, which may exacerbate pancreatic cell damage and inflammation after the onset of acute pancreatitis. Here, SLC38A1 is linked to Other metabolic disease.